title: Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients.
abstract: End-stage renal disease is a chronic and progressive pathology associated with several comorbidities, particularly diabetes. Indeed, diabetes is the first cause of end-stage renal disease and, in France, 42% of incident patients had diabetes in 2012. In the general population, diabetes is associated with increased cancer risk. The aim of this study was to examine the association between risk of cancer death and diabetes in a large French cohort of patients with end-stage renal disease. Data on all patients with end-stage renal disease who initiated dialysis in France between 2002 and 2009 were extracted from the Renal Epidemiology Information Network registry. The risk of dying by cancer was studied using the Fine and Gray model to take into account the competing risk of death by other causes. We analyzed 39,811 patients with end-stage renal disease. Their mean age was 67.7±15 years, 39.4% had diabetes and 55.3% at least one cardiovascular disease. Compared with the non-diabetic group, patients with diabetes were older and had more cardiovascular and respiratory comorbidities when they started dialysis. Conversely, fewer diabetic patients had also a tumor at the beginning of the renal replacement therapy. Cancer was indicated as the cause of death for 6.7% of diabetic and 13.4% of non-diabetic patients. The Fine and Gray multivariate analyses indicated that diabetes (HR=0.72 95% CI: [0.68-0.95], p<0.001) and also female gender, peritoneal dialysis, cardio-vascular disease and kidney transplantation were associated with decreased risk of death by cancer. In this French cohort of patients with end-stage renal disease, diabetes was not associated with a significant increased risk of dying from cancer. Studies on the incidence of cancer in patients with ESRD are now needed to evaluate the potential association between diabetes and specific malignancies in this population.
authors.affiliation: Département d'Epidémiologie et de Biostatistiques EHESP, Rennes, France; Université Rennes 1, UMR CNRS 6290, Rennes, France.
authors.forename: Adélaïde
authors.initials: A
authors.lastname: Pladys
authors.affiliation: Registre REIN, Agence de la biomédecine, La Plaine Saint Denis, France.
authors.forename: Cécile
authors.initials: C
authors.lastname: Couchoud
authors.affiliation: CHU Pontchaillou, service de néphrologie, Rennes, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: LeGuillou
authors.affiliation: CHU Pontchaillou, service de néphrologie, Rennes, France.
authors.forename: Muriel
authors.initials: M
authors.lastname: Siebert
authors.affiliation: CHU Pontchaillou, service de néphrologie, Rennes, France; Université Rennes 1, UMR CNRS 6290, Rennes, France.
authors.forename: Cécile
authors.initials: C
authors.lastname: Vigneau
authors.affiliation: Département d'Epidémiologie et de Biostatistiques EHESP, Rennes, France; EA MOS EHESP, Rennes, France.
authors.forename: Sahar
authors.initials: S
authors.lastname: Bayat
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology*; D003956:Dialysis; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000209:etiology / Q000401:mortality*; D012189:Retrospective Studies; D012307:Risk Factors